Engineers Gate Manager LP Cue Biopharma, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.49 - $5.92 $20,739 - $49,307
-8,329 Reduced 32.55%
17,260 $43,000
Q1 2022

May 16, 2022
BUY
$4.41 - $12.28 $16,974 - $47,265
3,849 Added 17.7%
25,589 $125,000
Q4 2021

Feb 14, 2022
BUY
$10.86 - $17.85 $236,096 - $388,059
21,740 New
21,740 $246,000
Q3 2020

Nov 16, 2020
SELL
$15.05 - $23.54 $124,282 - $194,393
-8,258 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$12.7 - $30.73 $104,876 - $253,768
8,258 New
8,258 $202,000

Others Institutions Holding CUE

# of Institutions
54
Shares Held
14.1M
Call Options Held
14.4K
Put Options Held
2.6K
View Full List

About Cue Biopharma, Inc.

CUE Quotes by TradingView
  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $49.5M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email